72399-18-9

Basic information

• Product Name: Formaldehyde, O-(phenylmethyl)oxime
• Synonyms: O-Benzylformaldoxime;formaldehyde-(O-benzyl oxime );formaldehyde O-benzyl oxime;formaldehyde-O-benzyloxime;O-benzyl formaldoxime;Formaldehyd-(O-benzyl-oxim)
• CAS NO: 72399-18-9
• Molecular Formula: C8H9NO
• Molecular Weight: 135.166
• Mol File: 72399-18-9.mol
• Article Data: 19

Chemical Properties

• CAS DataBase Reference: Formaldehyde, O-(phenylmethyl)oxime(CAS DataBase Reference)
• NIST Chemistry Reference: Formaldehyde, O-(phenylmethyl)oxime(72399-18-9)
• EPA Substance Registry System: Formaldehyde, O-(phenylmethyl)oxime(72399-18-9)

Safety Data

• Hazardous Substances Data: 72399-18-9(Hazardous Substances Data)

Upstream product

• 2687-43-6 O-benzylhydoxylamine hydrochloride 
• 50-00-0 formaldehyd 
• 622-33-3 N-benzyloxyamine 

Downstream Products

• 71663-75-7 N-(benzyloxy)-3,3-dimethyl-2-azetidinone 
• 101518-64-3 1,3-Bis-benzyloxy-5-isopropyl-tetrahydro-pyrimidin-4-one 
• 791590-47-1 1-(benzyloxy)-3-pentylazetidin-2-one 
• 457897-19-7 (R)-1-(benzyloxy)-3-pentylazetidin-2-one 
• 457897-20-0 (R)-2-(((benzyloxy)amino)methyl)heptanoic acid 
• 457897-21-1 (2R)-2-({formyl[(phenylmethyl)oxy]amino}methyl)heptanoic acid 

Relevant articles and documents

Concise synthesis of 2-N-hydroxy-3,4-dihydroisoquinol-2-one: A bacterial siderophore and human 5-lipooxygenase inhibitor

A short synthesis of 2-N-hydroxy-3,4-dihydroisoquinol-2-one has been devised, which is based on the Castagnoli-Cushman reaction and 3 times more high-yielding compared to an earlier reported sequence.

SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF

Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.

HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE

Disclosed are compounds having the formula: (I) wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP1, TLL1 and/or TLL2 activity.